Wuhan Healthgen Biotechnology Competitors and Similar CompaniesClear all
Wuhan Healthgen Biotechnology's competitors and similar companies include Innovent Biologics, Taiwan Liposome, Disc Medicine and Roivant Sciences.
 Wuhan Healthgen Biotechnology Wuhan Healthgen Biotechnology focuses on the development, manufacture, and marketing of plant-derived recombinant human proteins. |  Innovent Biologics Innovent Biologics is a biopharmaceutical company developing and manufacturing monoclonal antibodies. |  Taiwan Liposome Taiwan Liposome is a pharmaceutical company dedicated to the development and commercialization of novel nanomedicines that combine its proprietary lipid-assembled drug delivery platform with approved active pharmaceutical ingredients (APIs). |  Disc Medicine Disc Medicine (formerly known as Gemini Therapeutics) is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of treatments for patients suffering from hematologic diseases.
| ||
Founding Date | Founding Date 2006 | Founding Date 2011 | Founding Date 1997 | Founding Date 2017 | Founding Date 2014 |
Type | Type Private | Type Private | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations Wuhan Shi, CN HQ | Locations Fangshan Qu, CN HQ | Locations Taipei, TW HQ 港区, JP Leiden, NL South San Francisco, US | Locations Watertown, US HQ | Locations London, GB HQ Basel, CH Boston, US New York, US |
Employees | Employees 3 | Employees 831 | Employees 1652% decrease | Employees 15585% increase | Employees 908 |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 1.4 b | Valuation ($) 8.8 b |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) NT$101.9m (FY, 2020) | Revenue (est.) N/A | Revenue (est.) $8.3m (FY, 2025) |
Net income | Net income N/A | Net income N/A | Net income (NT$983.3m) (FY, 2020) | Net income ($212.2m) (FY, 2025) | Net income ($397.9m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 560m | Total funding raised N/A | Total funding raised $ 50m | Total funding raised $ 1.9b |
For sources of this data, please see the company profile
View Company Profiles
Innovent Biologics
HQ
Fangshan Qu, CN
Employees
831
Innovent Biologics is a biopharmaceutical company developing and manufacturing monoclonal antibodies.
View companyTaiwan Liposome
HQ
Taipei, TW
Employees
165↓ 2% decrease
Taiwan Liposome is a pharmaceutical company dedicated to the development and commercialization of novel nanomedicines that combine its proprietary lipid-assembled drug delivery platform with approved active pharmaceutical ingredients (APIs).
View companyDisc Medicine
HQ
Watertown, US
Employees
155
Disc Medicine (formerly known as Gemini Therapeutics) is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of treatments for patients suffering from hematologic diseases.
View company
Roivant Sciences
HQ
London, GB
Employees
908
Roivant Sciences is a company that develops and commercializes medicines.
View company